Delivery Order SPE2DB22D1106-SPE2DB24FDPC4

Award Date 12/3/23
Potential Completion Date 12/4/23
Potential Value $4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) for the medical product "BRIDION 200 MG/2 ML VIAL 2ML." The $2,357.76 firm-fixed-price contract has an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,935.22 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,617.27 firm-fixed-price delivery order is for the pharmaceutical product BRIDION 200 MG/2 ML VIAL 2ML. The award has an ultimate completion date of December 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vial (2 ml) pharmaceutical products to the Defense Logistics Agency (DLA). The $16,496.67 delivery order contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 26, 2024, with a completion date of February 27, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,740.33, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 23, 2024, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,328.64 firm fixed-price delivery order is for the medical supply "BRIDION 200 MG/2 ML VIAL 2ML" and has a completion date of November 7, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,125.97 delivery order contract is for the supply of Bridion 200 mg/2 ml vials, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of February 5, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a Delivery Order valued at $12,999.36 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML medical product, with a completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $2,708.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Bridion 200 mg/2 ml vial medical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,311.66 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 31, 2024. The contract was awarded on January 30, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDPC4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $3,953.84 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of December 4, 2023. The contract was awarded on December 3, 2023, with no set-aside designation, indicating open competition.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 5/12/25, 10:15 AM